GlassScriptPhysician profile
Sayali Yewale
NPI 1447600465
$345.86
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.07 · 2021: $178 · 2022: $55.60 · 2023: $19.29 · 2024: $77.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $96.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $96.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.78 | 2021 | |
| Glaxosmithkline, LLC. | $47.14 | 2022-2024 | Bexsero |
| Pfizer INC. | $33.62 | 2022-2023 | |
| Cranial Technologies, INC | $29.90 | 2024 | Doc Band |
| Sanofi Pasteur INC. | $21.89 | 2022 | |
| Novo Nordisk INC | $21.53 | 2021 | |
| Ibsa Pharma INC. | $20.11 | 2021 | |
| Rhythm Pharmaceuticals, INC. | $19.76 | 2024 | Imcivree |
| Corcept Therapeutics | $18.14 | 2021 | |
| Becton, Dickinson and Company | $16.82 | 2021 | |
| Merck Sharp & Dohme LLC | $16.32 | 2021 | |
| Shire North American Group INC | $15.07 | 2019 | |
| Tandem Diabetes Care, INC. | $15.00 | 2021 | |
| Medtronic, INC. | $14.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sayali Yewale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.